Takeda ups its offer for Shire
Takeda has put forward a new proposed bid for Shire, increasing the cash portion of the deal. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/takeda_ups_its_offer_for_shire_1232830
Search results
Found 7,457 pages
AUTHOR: Selina McKee
EU OKs Mundipharma’s Neulasta biosimilar
The Mundipharma network of independent associated companies says European regulators have approved use of Pelmeg, a biosimilar of Amgen’s white blood cell booster Neulasta. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/eu_oks_mundipharmas_neulasta_biosimilar_1265039NHS under ‘intolerable’ strain
NHS Confederation chief executive Niall Dickson is warning that the NHS is “under intolerable strain”, after the latest performance data continue to show growing demand and missed targets. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/nhs_under_intolerable_strain_1244161GW completes Epidiolex submission
GW Pharmaceuticals and its US subsidiary Greenwich Biosciences have completed the rolling submission of Epidiolex as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two difficult-to-treat forms of
by Selina McKee
www.pharmatimes.com/news/gw_completes_epidiolex_submission_1209905Takeda gets US nod for Shire buy
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/takeda_gets_us_nod_for_shire_buy_1243748EU green light for new Humira biosimilar
The European Commission has approved Mylan and Fujifilm Kyowa Kirin Biologics’ Humira biosimiar Hulio. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/eu_green_light_for_new_humira_biosimilar_1252910Sanofi, MSD to dismantle vaccines JV
Sanofi Pasteur and MSD have announced the end of their European vaccines joint venture so that their own “distinct growth strategies” can be pursued instead. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/sanofi,_msd_to_dismantle_vaccines_jv_1020306Boehringer buys ViraTherapeutics
Boehringer Ingelheim has exercised an option to acquire all shares of oncolytic virus company ViraTherapeutics. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/boehringer_buys_viratherapeutics_1252039AZ completes acquisition of ZS Pharma
AstraZeneca has completed its $2.7-billion acquisition of ZS Pharma, bolstering its cardiovascular and metabolic disease portfolio. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_completes_acquisition_of_zs_pharma_972294Shire turns down Takeda’s advances
Shire has now confirmed that it has thus far rejected three merger proposals from Takeda, the last one being valued at around $44 billion. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/shire_turns_down_takedas_advances_1232652
